Comments
Loading...
GlucoTrack (GCTK) Forecast
NewsEarningsGlucoTrack (GCTK) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestGlucoTrack (NASDAQ:GCTK) Stock Quotes, Forecast and News Summary
GlucoTrack Stock (NASDAQ: GCTK) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy GlucoTrack (GCTK) stock?
You can purchase shares of GlucoTrack (NASDAQ:GCTK) through any online brokerage.
Who are GlucoTrack (GCTK) competitors?
Other companies in GlucoTrack’s space includes: NeuroMetrix (NASDAQ:NURO), Catheter Precision (AMEX:VTAK), ENDRA Life Sciences (NASDAQ:NDRA), Bluejay Diagnostics (NASDAQ:BJDX) and Venus Concept (NASDAQ:VERO).
What is the forecast, or price target, for GlucoTrack (GCTK) stock?
There is no analysis for GlucoTrack to provide a consensus price target.
What is the current price for GlucoTrack (GCTK)?
The stock price for GlucoTrack (NASDAQ: GCTK) is $0.417701 last updated February 19, 2025 at 2:50 PM EST.
Does GlucoTrack (GCTK) pay a dividend?
There are no upcoming dividends for GlucoTrack.
When is GlucoTrack (NASDAQ:GCTK) reporting earnings?
GlucoTrack’s Q1 earnings are confirmed for Wednesday, May 14, 2025.
Is GlucoTrack (GCTK) going to split?
There is no upcoming split for GlucoTrack.
What sector and industry does GlucoTrack (GCTK) operate in?
GlucoTrack is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.